Resmed (RSMDF) Total Non-Current Liabilities (2010 - 2026)

Resmed (RSMDF) has reported Total Non-Current Liabilities for 17 consecutive years, with $985.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Non-Current Liabilities fell 17.01% year-over-year to $985.4 million; the trailing twelve-month figure through Jun 2026 stood at $985.4 million (down 17.01% YoY), and the FY2026 full-year result was $985.4 million, down 17.01% from the prior year.
• Total Non-Current Liabilities advanced to $985.4 million in Q2 2026 per RSMDF's latest filing, from $941.2 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $2.2 billion in Q4 2022 and bottomed at $931.6 million in Q3 2025.
• Historically, Total Non-Current Liabilities has averaged $1.3 billion across 5 years, with a median of $1.1 billion in 2024.
• The sharpest annual moves came in 2022 and 2024: Total Non-Current Liabilities jumped 127.85% in 2022, then plunged 41.09% in 2024.
• Over 5 years, Total Non-Current Liabilities stood at $2.2 billion in 2022, then fell by 24.76% to $1.7 billion in 2023, then tumbled by 37.54% to $1.0 billion in 2024, then fell by 9.84% to $934.4 million in 2025, then climbed by 5.47% to $985.4 million in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $985.4 million, $941.2 million, and $934.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.